Anti-Human CD45 Antibody [BC8] -Low Endotoxin, Azide Free (AGEL5083)

Anti-Human CD45 Antibody [BC8] -Low Endotoxin, Azide Free

The Anti-Human CD45 Antibody [BC8] -Low Endotoxin, Azide Free is a highly specific monoclonal antibody designed to recognize and bind the CD45 antigen with exceptional affinity and selectivity. This antibody has been developed using advanced hybridoma technology and produced in Mouse hosts, resulting in an Mouse IgG1, κ antibody that exhibits superior binding characteristics. The product is engineered for use in Human samples and has been thoroughly validated across multiple experimental platforms. With a concentration of ≥ 1 mg/mL, this antibody provides optimal performance in both qualitative and quantitative applications. This makes it an invaluable tool for researchers investigating CD45-related biological processes and cellular functions.

This antibody is particularly well-suited for FCM applications. It has been verified to perform reliably with Verified Samples in FCM: Human peripheral blood. The high purity and specificity of this reagent ensure minimal cross-reactivity and background noise, enabling researchers to obtain clear and reproducible results. Its versatility extends across multiple experimental methodologies, including flow cytometry, immunohistochemistry, Western blotting, and immunoprecipitation assays. The antibody's robust performance characteristics, combined with its ease of use and compatibility with standard laboratory protocols, make it an excellent choice for both basic research and translational studies. Researchers utilizing this antibody can expect consistent, high-quality results that facilitate meaningful scientific discoveries and advance understanding of CD45 function in health and disease.